Bio-Rad Laboratories to Host Third International Conference on TSEs

International Scientific Experts to Discuss BSE, Scrapie and Chronic Wasting Disease

MARNES-LA-COQUETTE, France, November 24, 2003 /PRNewswire-FirstCall/ -- Bio-Rad Laboratories, Inc. , a multinational manufacturer and distributor of life science research products and clinical diagnostics, announced today that it will host its third international conference on Transmissible Spongiform Encephalopathies (TSEs) on December 11, 2003 in Paris, France.

"Bio-Rad is honored to host a forum that brings together leading scientists, policy makers and customers to exchange ideas and learn the latest about new research," said Brad Crutchfield, Bio-Rad Vice President of Life Science.

Comprehensive Conference Program To Focus On Latest Research, Diagnostics

The conference will open with presentations on the latest advancements in research on prions and new trends in TSE diagnostics. Scientific presentations will include the physiological role of the prion protein, the transconformation of PrP, abnormal PrP detection, antemortem identification of TSEs from serum using infrared spectroscopy and the search for surrogate markers. Scientific specialists presenting their research include Dr. Corinne Lasmezas (French Atomic Energy Commission), Prof. Detlev Riesner (University of Dusseldorf, Germany), Dr. Roy Jackman (U.K. Veterinary Laboratories Agency), Dr. Peter Lasch (Robert Koch Institute, Germany) and Dr. Jean-Philippe Deslys (French Atomic Energy Commission).

The conference will also feature three panel discussions on BSE, Scrapie and Chronic Wasting Disease, moderated by Dr. Jacques Grassi (Director of Pharmacology and Immunology at the French Atomic Energy Commission). The emergence of new strains of BSE will be explored by Dr. Angus Wear (U.K. Veterinary Laboratories Agency), Dr. Thierry Baron (French Food Safety Agency), Dr. Yokoyama (National Institute for Animal Health, Japan) and Dr. Sandra Honour (Agri-food Surveillance System Branch, Alberta Food Safety Division, Canada). New discoveries in Scrapie detection will be discussed by Dr. Danny Matthews (U.K. Veterinary Laboratories Agency), Dr. Sylvie Lafond Benestad (Veterinaerinstituttet, Norway), Dr. Thierry Baron (French Food Safety Agency) and Dr. Mark Hall (National Veterinary Service Laboratories, U.S. Department of Agriculture). Sharing their experiences and views on the implementation of rapid tests for the diagnosis of CWD in North America will be: Mr. Bruce Morrison (Nebraska Game and Parks Division, U.S.) and Dr. Sandra Honour (Agri-food Surveillance System Branch, Alberta Food Safety Division, Canada).

The conference will be held at the Paris Congress (Equinoxe Salon) located at 20 rue du Colonel Pierre Avia, 75015, from 2.00 -- 6.30 pm. For more information send an email to: . www.tse.meeting@bio-rad.com

Bio-Rad Laboratories, Inc. () is a multinational manufacturer and distributor of life science research products and clinical diagnostics. It is based in Hercules, California, and serves more than 70,000 research and industry customers worldwide through a network of more than 30 wholly owned subsidiary offices. For more than 50 years, Bio-Rad has provided innovative technological solutions to help accelerate the pace of scientific discovery and protect human health. http://www.bio-rad.com/

Various statements made within this press release may constitute "forward-looking statements" for purposes of the Securities and Exchange Commission's "safe harbor" provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. The forward-looking statements contained herein involve risks and uncertainties that could cause results to differ materially from the Company's expectations.

CONTACT: Guillaume Camard of Bio-Rad Laboratories, Inc. France,+ 33 01 47 95 62 61, or ; or Susan Berg, CorporateCommunications of Bio-Rad Laboratories, Inc., +1-510-741-6063, or guillaume_camard@bio-rad.com susan_berg@bio-rad.com

Web site: http://www.bio-rad.com/

Terms and conditions of use apply
Copyright © 2003 PR Newswire Association LLC. All rights reserved.
A United Business Media Company

Posted: November 2003

View comments

Hide
(web4)